Bengaluru — Doctors in Europe will soon be able to treat Covid-19 patients with Gilead's antiviral drug, remdesivir, after the health regulator's endorsement put it on track to become the first therapy for the disease on the continent.

The European Medicines Agency (EMA) said on Thursday its human medicines committee recommended conditionally approving the drug for adults and adolescents from 12 years of age who are also suffering from pneumonia and require oxygen support. ..

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as articles from our international business news partners; ProfileData financial data; and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.



Questions or problems? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now